Background
hyper-inflammatory, hypoxic respiratory illness
SARS-COV-2 INFECTION
SARS-CoV-2 infections caused mild-to-moderate illness. However, a sizable portion of infected people experience a rapid progression of hyper-inflammatory and hypoxic respiratory illness that necessitates an effective and safer remedy to combat COVID-19.